These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22238484)

  • 1. Evaluation of a haemostatic agent in rabbits.
    Turhan N; Bilgili H; Captug O; Kurt M; Shorbagi A; Beyazit Y; Kurt OK; Kosar A; Haznedaroglu IC
    Afr J Tradit Complement Altern Med; 2011; 8(1):61-5. PubMed ID: 22238484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model.
    Bilgili H; Kosar A; Kurt M; Onal IK; Goker H; Captug O; Shorbagi A; Turgut M; Kekilli M; Kurt OK; Kirazli S; Aksu S; Haznedaroglu IC
    Med Princ Pract; 2009; 18(3):165-9. PubMed ID: 19349716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper.
    Haznedaroglu BZ; Haznedaroglu IC; Walker SL; Bilgili H; Goker H; Kosar A; Aktas A; Captug O; Kurt M; Ozdemir O; Kirazli S; Firat HC
    Clin Appl Thromb Hemost; 2010 Aug; 16(4):446-53. PubMed ID: 19833624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral systemic administration of Ankaferd blood stopper has no short-term toxicity in an in vivo rabbit experimental model.
    Bilgili H; Captug O; Kosar A; Kurt M; Kekilli M; Shorbagi A; Kurt OK; Ozdemir O; Goker H; Haznedaroglu IC
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):533-6. PubMed ID: 19605378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful management of bleeding after dental procedures with application of blood stopper: a single center prospective trial.
    Beyazit Y; Kart T; Kuscu A; Arslan A; Kurt M; Aktas B; Kekilli M; Haznedaroglu I
    J Contemp Dent Pract; 2011 Sep; 12(5):379-84. PubMed ID: 22269200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content.
    Beyazit F; Beyazit Y; Tanoglu A; Haznedaroglu IC
    Med Hypotheses; 2020 Oct; 143():110150. PubMed ID: 32763660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of the histopathological and immunohistochemical effects of a novel hemostatic agent, Ankaferd Blood Stopper, on vascular tissue in a rat aortic bleeding model.
    Kandemir O; Buyukates M; Kandemir NO; Aktunc E; Gul AE; Gul S; Turan SA
    J Cardiothorac Surg; 2010 Nov; 5():110. PubMed ID: 21073754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hemostatic effects of Ankaferd as an alternative medicine.
    Beyazit Y; Kurt M; Kekilli M; Goker H; Haznedaroglu IC
    Altern Med Rev; 2010 Dec; 15(4):329-36. PubMed ID: 21194248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of microporous polysaccharide hemospheres and Ankaferd Blood Stopper in a rabbit epistaxis model.
    Yurttas V; Sereflican M; Terzi EH; Ozyalvaçlı G; Kazaz H
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):933-8. PubMed ID: 26100031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemostatic role and histopathological effects of a new haemostatic agent in a rat bladder haemorrhage model: an experimental trial.
    Kilic O; Gonen M; Acar K; Yurdakul T; Avunduk MC; Esen HH; Oz M
    BJU Int; 2010 Jun; 105(12):1722-5. PubMed ID: 19849692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New hemostatic agent: the effect of Ankaferd Blood Stopper on healing wounds in experimental skin incision model.
    Yüce S; Çandirli C; Yenidünya S; Muslu B
    Turk J Med Sci; 2014; 44(2):288-94. PubMed ID: 25536739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability.
    Kurt M; Oztas E; Kuran S; Onal IK; Kekilli M; Haznedaroglu IC
    Am J Emerg Med; 2009 Jun; 27(5):631.e1-2. PubMed ID: 19497484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin.
    Cipil HS; Kosar A; Kaya A; Uz B; Haznedaroglu IC; Goker H; Ozdemir O; Koroglu M; Kirazli S; Firat HC
    Clin Appl Thromb Hemost; 2009; 15(3):270-6. PubMed ID: 19117967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: A retrospective analysis.
    Kurt M; Akdogan M; Onal IK; Kekilli M; Arhan M; Shorbagi A; Aksu S; Kurt OK; Haznedaroglu IC
    Dig Liver Dis; 2010 Mar; 42(3):196-9. PubMed ID: 19540818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model.
    Kosar A; Cipil HS; Kaya A; Uz B; Haznedaroglu IC; Goker H; Ozdemir O; Ercetin S; Kirazli S; Firat HC
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):185-90. PubMed ID: 19657315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a new hemostatic agent Ankaferd Blood Stopper in experimental liver laceration.
    Karakaya K; Ucan HB; Tascilar O; Emre AU; Cakmak GK; Irkorucu O; Ankarali H; Comert M
    J Invest Surg; 2009; 22(3):201-6. PubMed ID: 19466658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding due to slippage of elastic band during variceal ligation: successful use of Ankaferd blood stopper.
    Ozaslan E; Purnak T; Yildiz A; Haznedaroglu IC
    Indian J Gastroenterol; 2010 Jul; 29(4):166-8. PubMed ID: 20814774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Ankaferd hemostat application for the management of oral cavity bleedings in children with hemorrhagic diathesis.
    Leblebisatan G; Bay A; Karakus SC; Kekilli M; Haznedaroglu IC
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):494-7. PubMed ID: 22576286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis.
    Meric Teker A; Korkut AY; Kahya V; Gedikli O
    Eur Arch Otorhinolaryngol; 2010 Sep; 267(9):1377-81. PubMed ID: 20155359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat.
    Haznedaroglu BZ; Beyazit Y; Walker SL; Haznedaroglu IC
    Crit Rev Oncol Hematol; 2012 Jul; 83(1):21-34. PubMed ID: 22079213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.